A recently released preprint study shows that expanded telehealth coverage did not lead to an increase in volume for outpatient E&M services.
Subscribe today for full access
to all of these articles.
Researchers are actively developing PRTs for use in whole blood products to target bacteria and viruses, including SARS-CoV-2.
The precision medicine company recently announced a pair of strategic alliances aimed at expanding access to new cancer diagnostics.
Court rejects laundry list of defenses of a Texas hospital’s president who was convicted for his role in a $158 million PHP fraud scheme.
The FDA recently granted 510(k) clearance to StrivePD, a platform for collecting Parkinson’s patients’ symptom data via the Apple Watch.
The owner, who also owned several telemarketing companies and committed tax evasion of just over $4 million, now faces 14 years in prison.
The companies are working together to explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
Move to exclude testimony regarding potential patient impact of lab deficiencies as hearsay is dismissed by the court.
In clinical training sets, the new test allowed SARS-CoV-2 antibodies to be detected using widely available glucometers.
The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.
Combined with rising labor costs, COVID-19, and other challenges, stakeholders say the cuts will negatively impact patient care.
Experts offer advice in a recent commentary article on treating patients who may have monkeypox during the current COVID-19 pandemic.